On January 22nd, Philip Morris International (PMI) announced on its official website that an independent investigation commissioned by the company and conducted by Povaddo in 10 countries across Africa, the Americas, Asia, and Europe, revealed in a white paper titled "Innovation Under Pressure: Harnessing Complexity to Drive Change" that the majority of people believe innovation has the potential to address key issues in the next 10 to 20 years.
The survey results indicate that innovation faces many challenges in driving social change, including misleading information, outdated biases, and policymakers struggling to keep pace with rapid technological advancements. About 80% of respondents believe that misleading information weakens the application of crucial innovations, while 90% of respondents agree that it is crucial for the government to ensure that the public has access to accurate innovation information and to establish clear and fair regulatory measures.
A survey showed that approximately three-quarters (71%) of respondents believe that disruptive innovation can promote the development and deployment of vaccines, while nearly two-thirds (62%) believe that innovation can ensure everyone has access to high-quality and affordable healthcare services. However, there is a significant divergence of opinion on whether innovation can reduce smoking rates (49%) and illegal drug use (43%), reflecting the complexity and stubbornness of these issues.
While the public is optimistic about the opportunities brought by technology and innovation in the coming years (76% agree), the majority of people (74%) also agree that discussions around new innovations have become polarized, leading to consumer confusion. Furthermore, in these 10 countries, eight in ten citizens believe that misleading information is hindering progress.
The CEO of PMI, Jacek Olczak, stated that the company is committed to creating healthier alternatives to cigarettes through scientific and technological innovation, with a focus on global public health. However, the progress of innovation is often hindered by misunderstandings. Olczak emphasized that before dismissing the possibility of innovation, especially policymakers, should take the time to review scientific and public health evidence and make decisions based on facts rather than outdated assumptions.
The evidence supporting smoke-free alternatives to cigarettes is increasing, as seen in countries like Sweden with the lowest smoking rates in Europe, or Japan where smoking rates have decreased by 45% since introducing heated tobacco products in 2014. In other industries, accepting such innovation and allowing it to replace more harmful products is considered common sense. A small minority of opponents should not hinder the progress of around 1 billion adult smokers worldwide and public health.
Roughly two-thirds of survey participants (64%) are concerned that the pace of technological change is too fast for society and the economy to adapt. Respondents also pointed out a lack of information about the pros and cons of these innovations, public skepticism and distrust (often driven by social media), and thorny ethical issues. The public is looking to the government to take action and accelerate the adoption of advancements that can have a positive impact. The vast majority (90%) of respondents believe that it is very important for the government to ensure that the public has access to accurate information and establish clear and fair regulations. In addition, 87% emphasized the government's responsibility to address the challenge of misleading information, 83% highlighted the importance of public-private sector collaboration, and 82% believed it is necessary to promote open and balanced public debate on emerging innovations.
PMI calls on governments, public health institutions, and civil society to embrace proactive change and engage in constructive dialogue based on science and evidence.
The methodology of this survey is based on an international survey conducted by Povaddo from December 13th to 27th, 2024. The survey included 10,250 ordinary citizens aged 21 and above in 10 countries: Argentina, Brazil, France, Italy, Mexico, South Africa, South Korea, Spain, the United Kingdom, and the United States. The overall margin of error for the survey results is ±1%.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
